Pappa, V.; Bouchla, A.; Terpos, E.; Thomopoulos, T.P.; Rosati, M.; Stellas, D.; Antoniadou, A.; Mentis, A.; Papageorgiou, S.G.; Politou, M.;
et al. A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms 2021, 9, 806.
https://doi.org/10.3390/microorganisms9040806
AMA Style
Pappa V, Bouchla A, Terpos E, Thomopoulos TP, Rosati M, Stellas D, Antoniadou A, Mentis A, Papageorgiou SG, Politou M,
et al. A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms. 2021; 9(4):806.
https://doi.org/10.3390/microorganisms9040806
Chicago/Turabian Style
Pappa, Vasiliki, Anthi Bouchla, Evangelos Terpos, Thomas P. Thomopoulos, Margherita Rosati, Dimitris Stellas, Anastasia Antoniadou, Andreas Mentis, Sotirios G. Papageorgiou, Marianna Politou,
and et al. 2021. "A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis" Microorganisms 9, no. 4: 806.
https://doi.org/10.3390/microorganisms9040806
APA Style
Pappa, V., Bouchla, A., Terpos, E., Thomopoulos, T. P., Rosati, M., Stellas, D., Antoniadou, A., Mentis, A., Papageorgiou, S. G., Politou, M., Kotanidou, A., Kalomenidis, I., Poulakou, G., Jahaj, E., Korompoki, E., Grigoropoulou, S., Hu, X., Bear, J., Karaliota, S.,
... Dimopoulos, M.-A.
(2021). A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms, 9(4), 806.
https://doi.org/10.3390/microorganisms9040806